|
PALB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.815200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.034200E-01 |
| Normal-vs-Stage2 |
4.411800E-01 |
| Normal-vs-Stage3 |
8.646400E-01 |
| Normal-vs-Stage4 |
9.025200E-01 |
| Stage1-vs-Stage2 |
4.949200E-01 |
| Stage1-vs-Stage3 |
8.104000E-01 |
| Stage1-vs-Stage4 |
8.142800E-01 |
| Stage2-vs-Stage3 |
4.478800E-01 |
| Stage2-vs-Stage4 |
4.414800E-01 |
| Stage3-vs-Stage4 |
9.660400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.150200E-01 |
| Normal-vs-AfricanAmerican |
8.087800E-01 |
| Normal-vs-Asian |
8.432600E-01 |
| Caucasian-vs-AfricanAmerican |
8.254600E-01 |
| Caucasian-vs-Asian |
8.699400E-01 |
| AfricanAmerican-vs-Asian |
9.310200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.321400E-01 |
| Normal-vs-Female |
7.279200E-01 |
| Male-vs-Female |
7.878800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.722000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.385800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.440200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.322000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.676800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.024600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.762800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.189800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.654400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.217000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.200600E-01 |
| Classical-VS-Follicular |
6.47559999999991E-05 |
| Classical-VS-Other |
4.433000E-01 |
| Classical-VS-Normal |
6.841600E-01 |
| Tall-VS-Follicular |
9.809900E-04 |
| Tall-VS-Other |
2.139800E-01 |
| Tall-VS-Normal |
2.477000E-01 |
| Follicular-VS-Other |
6.022600E-01 |
| Follicular-VS-Normal |
3.022000E-02 |
| Other-VS-Normal |
6.430200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.670800E-01 |
| Normal-vs-N1 |
6.431600E-01 |
| N0-vs-N1 |
7.709400E-01 |
|
|
